October 11, 2018
Drugmaker KVK-Tech Inc. asked a Pennsylvania federal judge Thursday to give his blessing to a $3.8 million arbitration award it won over claims that ECR Pharmaceuticals Co. Inc. backed out of a five-year deal to purchase a cold medication to sell under its brand name.